Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | MGLL | Q99685 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | TSPO | P30536 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29476063 | 1.00 | L3MBTL1 (0.53) | L3MBTL1KDM4EATMMGLLCA1 | |
| SCHEMBL854107 | 1.00 | L3MBTL1 (0.53) | L3MBTL1KDM4EATMMGLLCA1 | |
| SCHEMBL30704778 | 1.00 | L3MBTL1 (0.53) | L3MBTL1KDM4EATMMGLLCA1 | |
| SCHEMBL16475872 | 0.97 | MGLL (0.50) | L3MBTL1KDM4EATMMGLLCA1 | |
| SCHEMBL15335253 | 0.97 | KDM4E (0.53) | L3MBTL1KDM4EATMMGLLCA1 | |
| SCHEMBL29509729 | 0.97 | KDM4E (0.53) | L3MBTL1KDM4EATMMGLLCA1 | |
| SCHEMBL31576186 | 0.97 | KDM4E (0.53) | L3MBTL1KDM4EATMMGLLCA1 | |
| SCHEMBL12415353 | 0.96 | MGLL (0.51) | L3MBTL1KDM4EATMMGLLCA1 | |
| SCHEMBL1714800 | 0.96 | MGLL (0.51) | L3MBTL1KDM4EATMMGLLCA1 | |
| SCHEMBL12093497 | 0.94 | KDM4E (0.53) | L3MBTL1KDM4EATMMGLLCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210217966-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-07-15 | — | — | US | disclosed |
| US-10991892-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-04-27 | — | — | US | disclosed |
| EP-2875019-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2017-03-29 | — | — | EP | disclosed |
| US-20150214489-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2015-07-30 | — | — | US | disclosed |
| US-20150214489-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2015-07-30 | — | — | US | disclosed |
| US-8283855-B2 | Method for synthesis of anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-8283855-B2 | Method for synthesis of anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | CYP1A1, AHR, CYP2C9 | L3MBTL1 4147/4885KDM4E 811/4885ATM 1577/4885 |
| US-20150214489-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MT-CO3, MT-ND3, MT-ND5 | L3MBTL1 2040/4885KDM4E 2392/4885ATM 2816/4885 |
| US-20210217966-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MT-CO3, MT-ND3, MT-ND5 | L3MBTL1 2040/4885KDM4E 2392/4885ATM 2816/4885 |
| US-10991892-B2 | Materials for organic electroluminescent devices | MT-CO3, MT-ND3, MT-ND5 | L3MBTL1 2040/4885KDM4E 2392/4885ATM 2816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.